Cutaneous T Cell Lymphoma Reactive CD4+ Cytotoxic T Lymphocyte Clones Display a Th1 Cytokine Profile and Use a Fas-Independent Pathway for Specific Tumor Cell Lysis
- 1 July 2000
- journal article
- case report
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 115 (1), 74-80
- https://doi.org/10.1046/j.1523-1747.2000.00995.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- CD4+ Epstein–Barr Virus-Specific Cytotoxic T-Lymphocytes from Human Umbilical Cord BloodCellular Immunology, 1999
- Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 functionOncogene, 1997
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- QUANTITATIVE ANALYSIS OF T HELPER 1, T HELPER 2, AND INFLAMMATORY CYTOKINE EXPRESSION IN PATIENTS AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1997
- TCRAlpha/Beta and TCRGamma/Delta CD4− /CD8− HLA-DR alloreactive CTL clones do not use fas/fas ligand pathway to lyse their specific target cellsHuman Immunology, 1996
- CD7-positive Sézary syndrome with a Th1 cytokine profileJournal of the American Academy of Dermatology, 1996
- Mechanism and Biological Significance of CD4‐mediated CytotoxicityImmunological Reviews, 1995
- Mycosis fungoides skin lesions contain CD8+ tumor‐infiltrating lymphocytes expressing an activated, MHC‐restricted cytotoxic T‐lymphocyte phenotypeJournal of Cutaneous Pathology, 1994
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987